Neuroone Medical Technologies (NMTC) Operating Margin (2011 - 2026)
Neuroone Medical Technologies (NMTC) reported Operating Margin of 128.74% for Q1 2026, up 6455.0% year-over-year from 1.96% in Q1 2025, and down 118.12% sequentially from 59.02% in Q4 2025.
Neuroone Medical Technologies (NMTC) Operating Margin (2011 - 2026) Analysis & Trends
Neuroone Medical Technologies has disclosed Operating Margin across 12 years of filings, most recently posting 128.74% for Q1 2026.
- Quarterly Operating Margin rose 6455.0% year-over-year to 128.74% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 80.1% (up 3415.0% YoY) and the FY2025 annual result came in at 46.46%, up 29780.0% from the prior year.
- Operating Margin declined to 128.74% in Q1 2026, from 59.02% in the prior quarter.
- Across five years, Operating Margin topped out at 52.26% in Q4 2024 and bottomed at 8616.29% in Q2 2022.
- The 5-year median for Operating Margin is 346.8% (2023), against an average of 1454.47%.
- Year-over-year, Operating Margin plunged 104696 bps in 2022 and surged 805902 bps in 2023.
- Neuroone Medical Technologies' Operating Margin stood at 1557.31% in 2022, then jumped by 78 bps to 346.8% in 2023, then surged by 115 bps to 52.26% in 2024, then tumbled by 213 bps to 59.02% in 2025, then sank by 118 bps to 128.74% in 2026.
- According to Business Quant data, Operating Margin over the past three periods registered 128.74%, 59.02%, and 50.02% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.17% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 19.94% |
| 10 | Neuroone Medical Technologies | 26.73 Mn | 23.93 Mn | 990,264.00 | -128.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -128.74% |
| Dec 31, 2025 | -59.02% |
| Sep 30, 2025 | -50.02% |
| Jun 30, 2025 | -111.23% |
| Mar 31, 2025 | -193.29% |
| Dec 31, 2024 | 52.26% |
| Sep 30, 2024 | -1,034.48% |
| Jun 30, 2024 | -338.34% |
| Mar 31, 2024 | -209.55% |
| Dec 31, 2023 | -346.80% |
| Sep 30, 2023 | -426.64% |
| Jun 30, 2023 | -557.26% |
| Mar 31, 2023 | -749.91% |
| Dec 31, 2022 | -1,557.31% |
| Sep 30, 2022 | -2,035.52% |
| Jun 30, 2022 | -8,616.29% |
| Mar 31, 2022 | -8,363.79% |
| Dec 31, 2021 | -8,324.42% |
| Sep 30, 2021 | -5,470.30% |
| Jun 30, 2021 | -7,569.32% |